Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Gilead Sciences
Biotech
Topics

Advertisement

Gilead Sciences

Share

Top Latest Popular

In the last half hour

California Justices Scrutinize Gilead Patients’ Liability Theory Bloomberg Law 22:16

In the last 2 hours

California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' The Charlotte Observer 20:36

In the last 4 hours

Fourth Circuit Skeptical of ‘Gray Market’ Drug Import Vendors Bloomberg Law 20:14

Advertisement

Advertisement

Earlier Today

California's highest court to consider whether drugmakers have 'duty to innovate' The Charlotte Observer 11:26

Earnings To Watch: Gilead Sciences (GILD) Reports Q1 Results Tomorrow Barchart 04:40

Yesterday

Gilead Fights ‘Limitless’ Liability at California High Court Bloomberg Law 15:00 Tue, 05 May

Clio Health Champions: Jenny Yun, Senior Director, U.S. HIV Prevention Marketing – Gilead Sciences Muse by Clio 13:51 Tue, 05 May

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain The Tribune, California 11:30 Tue, 05 May

Monday

Curious about Gilead (GILD) Q1 Performance? Explore Wall Street Estimates for Key Metrics Zacks 15:21 Mon, 04 May

The “Duty to Innovate” Arrives at the California Supreme Court: Oral Argument Set for May 6, 2026 Drug & Device Law 10:03 Mon, 04 May

Advertisement

Saturday

PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 17:42 Sat, 02 May

Friday

The Freelux Project Announces “The Butch Queen’s Brunch & Conversations Tour” Powered by Gilead Sciences GLAAD 16:44 Fri, 01 May

Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences Business Wire (Press Release) 11:04 Fri, 01 May

Gilead Advances HIV And Oncology Pipeline As Shares Trade Below Targets Simply Wall St 06:56 Fri, 01 May

Thursday

Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know Zacks 23:50 Thu, 30 Apr

Gilead Sciences Stock Outlook: Is Wall Street Bullish or Bearish? Barchart 16:32 Thu, 30 Apr

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Zacks 15:10 Thu, 30 Apr

In the last month

U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir Business Wire (Press Release) 13:34 Wed, 29 Apr

STAT Plus: AIDS group sues Trump administration over undisclosed agreement with Gilead STAT 23:21 Tue, 28 Apr

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel Business Wire (Press Release) 13:46 Tue, 28 Apr

Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV Labiotech 14:07 Mon, 27 Apr

This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people The Guam Daily Post 07:34 Mon, 27 Apr

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts Zacks 23:55 Fri, 24 Apr

Relative Strength Alert For Gilead Sciences Nasdaq 21:27 Fri, 24 Apr

The Generation to End HIV: Empowered College Leaders and Queer Storytellers Deliver Lifesaving Message to GenZ in HBCU Campus Tour GLAAD 17:44 Fri, 24 Apr

Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 Business Wire (Press Release) 21:05 Wed, 22 Apr

What's Going On With Arcus Biosciences Stock On Wednesday? Benzinga 20:23 Wed, 22 Apr

South Africa: Who Controls South Africa's Lenacapavir Rollout? Not South Africa AllAfrica 05:51 Wed, 22 Apr

Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? Zacks 17:32 Tue, 21 Apr

Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors Zacks 00:01 Tue, 21 Apr

Gilead Leans Further Into Oncology With Arcellx And Tubulis Deals Simply Wall St 06:49 Sun, 19 Apr

How Investors Are Reacting To Gilead Sciences (GILD) Expanding No‑Profit Lenacapavir Access Globally Simply Wall St 18:41 Fri, 17 Apr

Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer Business Wire (Press Release) 13:39 Fri, 17 Apr

Beam Hits Peak As Gilead Lab Hub Rises Over Vintage Park Hoodline 21:02 Thu, 16 Apr

iShares Core High Dividend ETF Experiences Big Outflow Nasdaq 16:33 Thu, 16 Apr

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It Zacks 15:09 Thu, 16 Apr

Lenacapavir and the Long Road from ‘Miracle’ to Global Access Observer Research Foundation 11:36 Thu, 16 Apr

Gilead is not doing enough to expand access to groundbreaking HIV prevention medicine Doctors Without Borders (Press Release) 20:10 Wed, 15 Apr

US-Led Partnership To Provide 1 Mln Lenacapavir To Help End HIV Transmission RTT News 12:02 Wed, 15 Apr

Here's Why Gilead Sciences (GILD) Gained But Lagged the Market Today Zacks 00:04 Wed, 15 Apr

Advertisement

Advertisement

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna